The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 19, 2021
Filed:
Jun. 15, 2018
Applicants:
Muhammed Majeed, Edison, NJ (US);
Kalyanam Nagabhushanam, East Windsor, NJ (US);
Inventors:
Muhammed Majeed, Edison, NJ (US);
Kalyanam Nagabhushanam, East Windsor, NJ (US);
Assignee:
SAMI LABS LIMITED, Bangalore, IN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/352 (2006.01); A61P 27/06 (2006.01); A61P 25/28 (2006.01); A61P 25/16 (2006.01); A61P 39/00 (2006.01); A61K 31/353 (2006.01); A61K 9/00 (2006.01); A61K 36/185 (2006.01);
U.S. Cl.
CPC ...
A61K 31/352 (2013.01); A61K 31/353 (2013.01); A61K 36/185 (2013.01); A61P 25/16 (2018.01); A61P 25/28 (2018.01); A61P 27/06 (2018.01); A61P 39/00 (2018.01); A61K 9/0053 (2013.01);
Abstract
Disclosed are compositions containing not less than 10% w/w of oroxylin A, not less than 10% w/w of baicalein and not less than 2% w/w of chrysin for use in the therapeutic management of memory impairment and cognitive dysfunction. More specifically, the invention discloses the use of abovementioned compositions for the management of cognitive impairment induced by chemotherapy and hyperglycemia.